Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 7.47 INR
Change Today -0.39 / -4.96%
Volume 1.1K
GTL On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 03/26/15 All times are local (Market data is delayed by at least 15 minutes).

gujarat terce laboratories (GTL) Snapshot

Open
7.47
Previous Close
7.86
Day High
7.47
Day Low
7.47
52 Week High
05/26/14 - 13.07
52 Week Low
12/29/14 - 5.57
Market Cap
55.4M
Average Volume 10 Days
1.6K
EPS TTM
0.56
Shares Outstanding
7.4M
EX-Date
--
P/E TM
13.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for GUJARAT TERCE LABORATORIES (GTL)

Related News

No related news articles were found.

gujarat terce laboratories (GTL) Related Businessweek News

No Related Businessweek News Found

gujarat terce laboratories (GTL) Details

Gujarat Terce Laboratories Limited manufactures and sells pharmaceutical formulations in India. The company’s products include of antimicrobials, analgesic/anti-inflammatory and muscle relaxants, antacid/anti-ulcer agents, anti-allergic, anticough and cold, antiemetics, anti-malarials, antiparasitic and antibacterials, enzymes, haematinics, hormones, laxatives, nutritional supplements, steroids, urinary alkalizers, and utrine relaxants. It also offers formulations for cardiac and skin protection; and ayurvedic and psychotropic range of products. The company provides its products in various forms, such as tablets, capsules, oral liquids, ointments, syrups, and injections. It also exports its products. Gujarat Terce Laboratories Limited was founded in 1985 and is based in Ahmedabad, India.

Founded in 1985

gujarat terce laboratories (GTL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

gujarat terce laboratories (GTL) Key Developments

Gujarat Terce Laboratories Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Gujarat Terce Laboratories Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported total income from operations (net) of INR 61.864 million compared to INR 62.277 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1.556 million compared to INR 1.467 million a year ago. Profit from ordinary activities before tax was INR 0.714 million compared to INR 0.201 million a year ago. Net profit was INR 0.714 million or INR 0.10 per basic and diluted share before and after extra ordinary items compared to INR 0.201 million or INR 0.03 per basic and diluted share before and after extra ordinary items a year ago. For the nine months period, the company reported total income from operations (net) of INR 190.505 million compared to INR 175.759 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 3.779 million compared to INR 3.631 million a year ago. Profit from ordinary activities before tax was INR 0.927 million compared to INR 0.713 million a year ago. Net profit was INR 0.927 million or INR 0.12 per basic and diluted share before and after extra ordinary items compared to INR 0.713 million or INR 0.10 per basic and diluted share before and after extra ordinary items a year ago.

Gujarat Terce Laboratories Ltd., Board Meeting, Feb 13, 2015

Gujarat Terce Laboratories Ltd., Board Meeting, Feb 13, 2015. Agenda: To approve quarterly results.

Gujarat Terce Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the Second Quarter and First Half Year Ended September 30, 2014

Gujarat Terce Laboratories Ltd. announced unaudited standalone earnings results for the second quarter and first half year ended September 30, 2014. For the quarter, the company's net sales (net of excise duty) was INR 69.871 million compared to INR 67.690 million for the same period last year. Profit from operations before other income, finance cost and exceptional items was INR 2.121 million compared to INR 3.581 million for the same period last year. Profit from ordinary activities before tax was INR 0.744 million compared to INR 2.475 million for the same period last year. Net profit was INR 0.744 million compared to INR 2.475 million for the same period last year. For the half year, the company's net sales (net of excise duty) was INR 128.004 million compared to INR 113.447 million for the same period last year. Profit from operations before other income, finance cost and exceptional items was INR 2.223 million compared to INR 2.164 million for the same period last year. Profit from ordinary activities before tax was INR 0.213 million compared to INR 0.512 million for the same period last year. Net profit was INR 0.213 million compared to INR 0.512 million for the same period last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GTL:IN 7.47 INR -0.39

GTL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GTL.
View Industry Companies
 

Industry Analysis

GTL

Industry Average

Valuation GTL Industry Range
Price/Earnings 23.6x
Price/Sales 0.2x
Price/Book -- Not Meaningful
Price/Cash Flow 9.3x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUJARAT TERCE LABORATORIES, please visit www.gujaratterce.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.